Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 86


National healthcare budget impact analysis of the treatment for osteoporosis and fractures in Korea.

Yi H, Ha YC, Lee YK, Lim YT.

J Bone Metab. 2013 May;20(1):17-23. doi: 10.11005/jbm.2013.20.1.17. Epub 2013 May 13.


[Socioeconomic costs of stroke in Korea: estimated from the Korea national health insurance claims database].

Lim SJ, Kim HJ, Nam CM, Chang HS, Jang YH, Kim S, Kang HY.

J Prev Med Public Health. 2009 Jul;42(4):251-60. doi: 10.3961/jpmph.2009.42.4.251. Korean.


Utilization of DXA Bone Mineral Densitometry in Ontario: An Evidence-Based Analysis.

Health Quality Ontario.

Ont Health Technol Assess Ser. 2006;6(20):1-180. Epub 2006 Nov 1.


[The socioeconomic cost of injuries in South Korea].

Park K, Lee JS, Kim Y, Kim YI, Kim J.

J Prev Med Public Health. 2009 Jan;42(1):5-11. doi: 10.3961/jpmph.2009.42.1.5. Korean.


Cost-effectiveness of raloxifene in the treatment of osteoporosis in Chinese postmenopausal women: impact of medication persistence and adherence.

Chen M, Si L, Winzenberg TM, Gu J, Jiang Q, Palmer AJ.

Patient Prefer Adherence. 2016 Mar 29;10:415-23. doi: 10.2147/PPA.S100175. eCollection 2016.


Medical costs of osteoporosis in the elderly Medicare population.

Blume SW, Curtis JR.

Osteoporos Int. 2011 Jun;22(6):1835-44. doi: 10.1007/s00198-010-1419-7. Epub 2010 Dec 17.


Economic Impact of Atopic Dermatitis in Korean Patients.

Kim C, Park KY, Ahn S, Kim DH, Li K, Kim DW, Kim MB, Jo SJ, Yim HW, Seo SJ.

Ann Dermatol. 2015 Jun;27(3):298-305. doi: 10.5021/ad.2015.27.3.298. Epub 2015 May 29.


Economic Burden of Osteoporosis in South Korea: Claim Data of the National Health Insurance Service from 2008 to 2011.

Ha YC, Kim HY, Jang S, Lee YK, Kim TY.

Calcif Tissue Int. 2017 Sep 14. doi: 10.1007/s00223-017-0320-1. [Epub ahead of print]


The societal burden of HBV-related disease: South Korea.

Yang BM, Kim DJ, Byun KS, Kim HS, Park JW, Shin S.

Dig Dis Sci. 2010 Mar;55(3):784-93. doi: 10.1007/s10620-009-0786-4. Epub 2009 Mar 31.


Healthcare Costs for Acute Hospitalized and Chronic Heart Failure in South Korea: A Multi-Center Retrospective Cohort Study.

Ku H, Chung WJ, Lee HY, Yoo BS, Choi JO, Han SW, Jang J, Lee EK, Kang SM.

Yonsei Med J. 2017 Sep;58(5):944-953. doi: 10.3349/ymj.2017.58.5.944.


Healthcare Costs of Osteoporotic Fracture in Korea: Information from the National Health Insurance Claims Database, 2008-2011.

Kim HY, Ha YC, Kim TY, Cho H, Lee YK, Baek JY, Jang S.

J Bone Metab. 2017 May;24(2):125-133. doi: 10.11005/jbm.2017.24.2.125. Epub 2017 May 31.


Early results of pediatric appendicitis after adoption of diagnosis-related group-based payment system in South Korea.

Moon SB.

J Multidiscip Healthc. 2015 Nov 24;8:503-9. doi: 10.2147/JMDH.S95937. eCollection 2015.


Socioeconomic costs of overactive bladder and stress urinary incontinence in Korea.

Sung W, You H, Yoon TY, Lee SJ.

Int Neurourol J. 2012 Mar;16(1):23-9. doi: 10.5213/inj.2012.16.1.23. Epub 2012 Mar 31.


Evaluation of use and cost of medical care of common lumbar disorders in Korea: cross-sectional study of Korean Health Insurance Review and Assessment Service National Patient Sample data.

Ahn YJ, Shin JS, Lee J, Lee YJ, Kim MR, Park KB, Lee JH, Shin KM, Ha IH.

BMJ Open. 2016 Sep 12;6(9):e012432. doi: 10.1136/bmjopen-2016-012432.


Characteristics of Patients Diagnosed with Osteoporosis in South Korea: Results from the National Claim Registry.

Yoon HK, Lee YK, Ha YC.

J Bone Metab. 2017 Feb;24(1):59-63. doi: 10.11005/jbm.2017.24.1.59. Epub 2017 Feb 28.


Estimating medical expenditure associated with osteoporotic hip fracture in elderly Korean women based on the National Health Insurance Claims Database 2002-2004.

Kang HY, Park SE, Kang DR, Kim JY, Jang YH, Choi WJ, Moon SH, Yang KH, Park JY, Kwon SY.

Value Health. 2009 Nov-Dec;12 Suppl 3:S93-6. doi: 10.1111/j.1524-4733.2009.00637.x.


Direct healthcare costs of osteoporosis-related fractures in managed care patients receiving pharmacological osteoporosis therapy.

Viswanathan HN, Curtis JR, Yu J, White J, Stolshek BS, Merinar C, Balasubramanian A, Kallich JD, Adams JL, Wade SW.

Appl Health Econ Health Policy. 2012 May 1;10(3):163-73. doi: 10.2165/11598590-000000000-00000.


Health-economic comparison of three recommended drugs for the treatment of osteoporosis.

Brecht JG, Kruse HP, Möhrke W, Oestreich A, Huppertz E.

Int J Clin Pharmacol Res. 2004;24(1):1-10.


Supplemental Content

Support Center